# Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair

> **NCT03262688** · PHASE3 · UNKNOWN · sponsor: **Innocoll** · enrollment: 159 (estimated)

## Conditions studied

- Inguinal Hernia
- Postoperative Pain

## Interventions

- **DRUG:** Bupivacaine HCl collagen-matrix implant
- **DRUG:** Bupivacaine HCl infiltration

## Key facts

- **NCT ID:** NCT03262688
- **Lead sponsor:** Innocoll
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-16
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 159 (ESTIMATED)
- **Last updated:** 2021-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03262688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03262688, "Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03262688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*